Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
107,573,681
-
Number of holders
-
6
-
Total 13F shares, excl. options
-
854,891
-
Shares change
-
-34,799
-
Total reported value, excl. options
-
$3,376,000
-
Value change
-
-$143,145
-
Number of buys
-
2
-
Number of sells
-
-2
-
Price
-
$3.93
Significant Holders of VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) as of Q2 2015
8 filings reported holding VNRX - VOLITIONRX LTD - Common Stock, par value $0.001 per share as of Q2 2015.
VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) has 6 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 854,891 shares
of 107,573,681 outstanding shares and own 0.79% of the company stock.
Largest 8 shareholders include Southpoint Capital Advisors LP (800,000 shares), GARRISON BRADFORD & ASSOCIATES INC (15,500 shares), CREDIT SUISSE AG/ (11,969 shares), MORGAN STANLEY (11,500 shares), Commerzbank Aktiengesellschaft /FI (11,500 shares), UBS Group AG (4,422 shares), Spark Investment Management LLC (0 shares), and KCG Holdings, Inc. (0 shares).
This table shows the top 6 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.